Markets
Cumberland Pharmaceuticals Inc. (CPIX)
CPIXNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$5.28
-0.0900 (-1.68%) today
At the close, Nov 10, 4:00 PM ET. After hours $5.28 -0.38%
-1.68% 1D
- Market cap
- $79.41m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $5.09 to $5.58
- 52-week range
- $1.85 to $9.28
- Average volume
- 93.2k
- Previous close
- $5.37
Financials
| Quarter | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | $11.71m | $30.30m | $13.68m | $9.13m |
| Gross profit | $10.29m | $25.87m | $11.44m | $7.20m |
| Operating income | $1.29m | $4.42m | -$1.37m | -$3.13m |
| Net income | $1.26m | -$1.94m | -$1.41m | -$3.29m |
Last four quarters: revenue $64.82m, margin -8.3%, free cash flow –
News
8 latest- Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne CardiomyopathyMarketBeat · Oct 26, 2026
- Cumberland Pharma Reports Phase 2a Safety Data For Ifetroban In Systemic Sclerosis; Shares Slide RTTNews · Oct 23, 2026
- Cumberland Pharmaceuticals Inc. Announces Top-Line Results from Phase 2a ASSIST-SSc TrialFintel · Oct 23, 2026
- Tuesday Sector Leaders: Biotechnology, Drugs BNK Invest · Oct 20, 2026
- Biotech Stocks At 52-Week Highs - GENB +15%, BDSX +10%, CDNA +6%, CPIX +10%, CRDL +7% RTTNews · Aug 26, 2026
- Biotech Stocks At 52-Week Highs - SLN +29% & ABCL +34% On Positive Trial Data, CPIX, CLDX, BDSX RTTNews · Aug 11, 2026
- Cumberland Pharmaceuticals Q2 Earnings Call HighlightsMarketBeat · Aug 4, 2026
- Top Biotech Gainers: UPC Cuts Loss, CPIX Gains Ahead Of Q2 Results, AUTL Builds Commercial Momentum RTTNews · Aug 3, 2026
The company
Cumberland Pharmaceuticals Inc. is the largest biopharmaceutical company founded and headquartered in Tennessee and is focused on developing innovative products that improve the quality of patient care. The company is advancing a clinical pipeline of late-stage product candidates across multiple therapeutic areas with significant unmet medical needs.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- cumberlandpharma.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.